The effect of several natural and synthetic steroids on the activity of Δ 5,3β- hydroxysteroid dehydrogenase in homogenates of human placenta has been measured by a method which determines the conversion of labelled dehydroepiandrosterone to androstenedione, testosterone, estradiol-17β, and estrone and of labelled pregnenolone to progesterone and 5α-pregnane-3,20-dione. The method utilizes thin-layer chromatography systems and radio-gas-liquid chromatography which separate each steroidal product from each substrate. Enzymatic activity can be determined rapidly and efficiently in multiple samples of very small amounts of tissue. The present report demonstrates that nucleophilic substituents on, adjacent to, or at some distance from the site on the steroid molecule catalyzed by the enzyme may increase the inhibitory capacity of the parent steroid or confer inhibitory capacity to an inactive parent steroid. Selective inhibition of the conversion of pregnenolone by several steroids demonstrates substrate specificity of the C 19- and C 21-3β-hydroxysteroid dehydrogenases. The most potent of these selective inhibitors are, in descending order of inhibitory potency: 2α-bromo-17β-hydroxy-5α-androstane-3-one-17β-acetate; 3β,17α-dihydroxy-5-pregnene-3,20-dione-16α-nitrile; 3β-hydroxy-5α-pregnane-20-one-16α-nitrile; and 2α-bromo-5a-androstane-3,17-dione. The most potent inhibitors of both enzymes are 2α-cyano-4,4-dimethyl-2,3α-tetrahydrofuran-2-spiro-17,5-androstene-3-one and 6,16β-dimethyl-3β-hydroxy-5-pregnene-16α-nitrile. The usual form of cyanoketone (2α-cyano-17β-hydroxy-4,4,17α-trimethyl-5-androstene-3-one) does not inhibit either enzyme.
Read full abstract